Search

Your search keyword '"Tricot, Sabine"' showing total 195 results

Search Constraints

Start Over You searched for: Author "Tricot, Sabine" Remove constraint Author: "Tricot, Sabine"
195 results on '"Tricot, Sabine"'

Search Results

1. Non-human primate models of human respiratory infections

2. Long‐term results of Waldenström macroglobulinaemia treatment by bendamustine and rituximab: A study on behalf of the French Innovative Leukemia Organization (FILO)

4. Supplemental Table 3 Characteristics of patients with WM according to CXC4 mutation status from Genomic Landscape of CXCR4 Mutations in Waldenström Macroglobulinemia

5. Supplemental Table 1 Gene expression profilling from Genomic Landscape of CXCR4 Mutations in Waldenström Macroglobulinemia

6. Supplementary Table 1, Supplementary Figures 1-4 from TP53 Mutation and Its Prognostic Significance in Waldenstrom's Macroglobulinemia

7. List of pathways analyzed for GSEA from Genomic Landscape of CXCR4 Mutations in Waldenström Macroglobulinemia

8. Addition of Brentuximab Vedotin to Gemcitabine in Relapsed or Refractory T-Cell Lymphoma: Final Analysis of a Lysa Multicenter, Phase II Study. "the TOTAL Trial"

9. Long-Term Follow-up of Bendamustine Plus Rituximab Regimen in 69 Treatment Naïve (TN) Patients with Waldenström Macroglobulinemia, a Study on Behalf of the French Innovative Leukemia Organization (FILO)

10. Large α-aminonitrilase activity screening of nitrilase superfamily members: Access to conversion and enantiospecificity by LC–MS

11. MYD88 L265P mutation in Waldenstrom macroglobulinemia

13. Additional file 3 of Clostridium sticklandii, a specialist in amino acid degradation:revisiting its metabolism through its genome sequence

14. Additional file of Clostridium sticklandii, a specialist in amino acid degradation:revisiting its metabolism through its genome sequence

15. Additional file 11 of Clostridium sticklandii, a specialist in amino acid degradation:revisiting its metabolism through its genome sequence

16. Additional file 5 of Clostridium sticklandii, a specialist in amino acid degradation:revisiting its metabolism through its genome sequence

17. Additional file 6 of Clostridium sticklandii, a specialist in amino acid degradation:revisiting its metabolism through its genome sequence

18. Additional file 9 of Clostridium sticklandii, a specialist in amino acid degradation:revisiting its metabolism through its genome sequence

19. Additional file 7 of Clostridium sticklandii, a specialist in amino acid degradation:revisiting its metabolism through its genome sequence

20. Additional file 4 of Clostridium sticklandii, a specialist in amino acid degradation:revisiting its metabolism through its genome sequence

22. A conserved gene cluster rules anaerobic oxidative degradation of L-ornithine

23. Genome wide SNP array identified multiple mechanisms of genetic changes in Waldenstrom macroglobulinemia

26. Addition of Brentuximab Vedotin to Gemcitabine in Relapsed or Refractory T-Cell Lymphoma: Results of a Lysa Multicenter, Phase II Study. "the TOTAL Trial"

27. Characterizing Specificities of Chronic Lymphoid Leukemia Harboring a BCL2 rearrangement

29. Intradermal vaccination prevents anti-MOG autoimmune encephalomyelitis in macaques

30. Lenalidomide maintenance for diffuse large B-cell lymphoma patients responding to R-CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study

32. Lenalidomide maintenance for diffuse large B‐cell lymphoma patients responding to R‐CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study

34. Targeting MOG to skin macrophages prevents EAE in macaques through TGFβ-induced peripheral tolerance

35. The Frequencies of Immunosuppressive Cells in Adipose Tissue Differ in Human, Non-human Primate, and Mouse Models

36. Clostridium sticklandii, a specialist in amino acid degradation:revisiting its metabolism through its genome sequence

37. Lenalidomide maintenance for diffuse large B‐cell lymphoma patients responding to R‐CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study.

38. Bendamustine plus rituximab in newly‐diagnosed Waldenström macroglobulinaemia patients. A study on behalf of the French Innovative Leukaemia Organization (FILO)

39. TP53 Mutation and Its Prognostic Significance in Waldenstrom's Macroglobulinemia

40. Combination of t(4;14), del(17p13), del(1p32) and 1q21 gain FISH probes identifies clonal heterogeneity and enhances the detection of adverse cytogenetic profiles in 233 newly diagnosed multiple myeloma

42. Evaluating the Efficiency of Isotope Transmission for Improved Panel Design and a Comparison of the Detection Sensitivities of Mass Cytometer Instruments

43. Bendamustine plus rituximab in newly‐diagnosed Waldenström macroglobulinaemia patients. A study on behalf of the French Innovative Leukaemia Organization (FILO).

44. TP53 Mutation in Waldenstrom Macroglobulinemia

45. BACH2 promotes indolent clinical presentation in Waldenström macroglobulinemia

46. Genomic Landscape of CXCR4 Mutations in Waldenström Macroglobulinemia

47. Bendamustine Treatment in Refractory or Relapsed T Cell Lymphomas: A Retrospective Multicenter Study

48. Can Assessment of Patient Monoclonal Immunoglobulins By Heavy/Light Analysis be Used to Assign Patient Responses Analogous to IMWG Response Criteria?

50. Genomic Landscape of CXCR4 Mutations in Waldenstrom's Macroglobulinemia

Catalog

Books, media, physical & digital resources